MedPath

Adapted Hospital Discharge Intervention: the CONNECT Pilot

Not Applicable
Not yet recruiting
Conditions
Communication Research
Registration Number
NCT07032818
Lead Sponsor
Boston Medical Center
Brief Summary

Hospital discharge is a dangerous time for patients: one in five will suffer an adverse event, such as a medication error, and nearly 25% will be readmitted within 30 days. This time is even more dangerous for patients with who face communication barriers, including those with non-English language preference (NELP), low health literacy, and the elderly.

The investigators will pilot a post-discharge educational intervention to reinforce written discharge instructions (known as the After Visit Summary or AVS) using a randomized controlled trial design (2:1 intervention: control). The control group will receive current standard of care discharge education which includes a nurse reviewing their AVS and an automated call in English that allows patients to numerically select types of problems/questions that are then escalated to a nurse who should return their call within a few days. The intervention group will receive the standard of care discharge education with the AVS and an additional post-discharge educational call delivered by a registered nurse or other qualified health professional with the option to have written instructions professionally translated and sent via MyChart message--if available in their preferred language.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Registered language in Epic (written or spoken) is Spanish, Haitian Creole, Portuguese, Cape Verdean, or Vietnamese
  • Admitted to medicine team at Boston Medical Center (BMC)
  • Being discharged home (to the community)
Exclusion Criteria
  • On airborne infections precautions at time of recruitment
  • On C diff precautions at time of recruitment
  • On suicide precautions at time of recruitment
  • Nurse report of participant displaying cognitive impairment, ongoing delirium, or aggression
  • Discharge observed during a prior admission

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Retention success by linguistic group12 months

Number of enrolled participants who completed all study assessments stratified by linguistic group.

Fidelity to the intervention12 months

The number of scheduled educations calls that were completed for participants in the intervention arm based on nursing documentation in Epic.

Secondary Outcome Measures
NameTimeMethod
Acceptability of the intervention12 months

The Acceptability of Intervention Measure (AIM) will be completed by participants in the intervention arm to assess acceptability. It has four questions with 5 Likert responses where 1 = Completely disagree, 2 = Disagree, 3 = Neither agree nor disagree, 4 = Agree, 5 = Completely agree, The range of scores from 4 to 20 with higher scores indicating greater acceptability.

Feasibility of the intervention12 months

Feasibility will be assessed by the number of participants in the intervention arm whose educational call was language concordant based on nursing documentation in Epic.

Patient Understanding of Discharge Instruction (UDI) Scale12 months

Assessed by a composite score of six key domains of discharge instructions (primary diagnosis, self-care instructions, return precautions, medication changes, medication indications, follow-up) as determined by physician adjudicators (1=poor, 4 = near perfect). Higher scores demonstrate better understanding.

Trial Locations

Locations (1)

Boston Medical Center

🇺🇸

Boston, Massachusetts, United States

Boston Medical Center
🇺🇸Boston, Massachusetts, United States
Kirsten Austad, MD PhD
Contact
617-414-2050

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.